acquired
Stage
2012
Founded
2
Investors
About
Lipocalyx developed and provided Viromers®, high-tech polymers designed to deliver DNA and RNA into target cells for efficient genetic manipulation. This technology enabled gene silencing and RNA interference, particularly in hard-to-transfect cell types.
Explore lipocalyx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.